Raymond James & Associates Invitae Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$0.42 - $0.72 $496 - $851	-1,182 Reduced 6.56%	16,843 $10,000
Q3 2023 Oct 24, 2023	SELL	$0.6 - $1.53 $7,045 - $17,966	-11,743 Reduced 39.45%	18,025 $10,000
Q2 2023 Jul 25, 2023	BUY	$1.05 - $1.63 $2,795 - $4,339	2,662 Added 9.82%	29,768 $33,000
Q1 2023 Apr 14, 2023	SELL	$1.2 - $2.73 $3,076 - $6,999	-2,564 Reduced 8.64%	27,106 $36,000
Q4 2022 Feb 08, 2023	SELL	$1.71 - $3.61 $31,393 - $66,275	-18,359 Reduced 38.22%	29,670 $55,000
Q3 2022 Oct 25, 2022	BUY	$1.9 - $8.63 $6,976 - $31,689	3,672 Added 8.28%	48,029 $118,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $5,231 - $22,128	-2,456 Reduced 5.25%	44,357 $108,000
Q1 2022 May 11, 2022	SELL	$6.28 - $15.59 $187,062 - $464,379	-29,787 Reduced 38.89%	46,813 $373,000
Q4 2021 Feb 08, 2022	SELL	$14.7 - $28.67 $273,258 - $532,946	-18,589 Reduced 19.53%	76,600 $1.17 Million
Q3 2021 Nov 02, 2021	SELL	$24.31 - $33.6 $117,587 - $162,523	-4,837 Reduced 4.84%	95,189 $2.71 Million
Q2 2021 Aug 11, 2021	SELL	$26.09 - $40.4 $778,316 - $1.21 Million	-29,832 Reduced 22.97%	100,026 $3.37 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $1.17 Million - $2.02 Million	35,420 Added 37.51%	129,858 $4.96 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $2.5 Million - $3.67 Million	63,905 Added 209.3%	94,438 $3.95 Million
Q3 2020 Nov 04, 2020	BUY	$28.43 - $44.67 $499,543 - $784,896	17,571 Added 135.56%	30,533 $1.32 Million
Q2 2020 Jul 28, 2020	SELL	$11.71 - $30.29 $381,148 - $985,909	-32,549 Reduced 71.52%	12,962 $393,000
Q1 2020 Apr 21, 2020	SELL	$7.64 - $27.5 $73,473 - $264,467	-9,617 Reduced 17.44%	45,511 $622,000
Q4 2019 Feb 12, 2020	BUY	$15.02 - $20.57 $288,459 - $395,046	19,205 Added 53.46%	55,128 $889,000
Q3 2019 Nov 07, 2019	BUY	$18.85 - $27.5 $677,148 - $987,882	35,923 New	35,923 $692,000
Q4 2018 Feb 11, 2019	SELL	$9.26 - $16.38 $132,334 - $234,086	-14,291 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $107,754 - $261,668	14,291 New	14,291 $239,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account